All posts by: Michael Zand

About Michael Zand

Molecular time signalling controls stem cells during brain’s development – Medical Xpress

Continue reading

2014-11-13 NEWS

helpmeoutDOC News – A consistent flow of medical news

Molecular time signalling controls stem cells during brain’s development
Medical Xpress
Researchers at Karolinska Institutet in Sweden have succeeded in explaining how stem cells in the brain change to allow one type of stem cell to produce different cell types at different stages. In a study being published in the journal Neuron
International Stem Cell Corporation Announces Record Revenues and CNNMoney
Bone marrow stem cell treatment has no added benefit: StudyThe Hindu
Tumor suppressor also inhibits key property of stem cells, Stanford Science Codex
helpmeoutDOC News – A consistent flow of medical news –Business Standard
all 22 news articles »
Continue reading

2014-11-13 NEWS

Stanford Medical Center Report

Tumor suppressor also inhibits key property of stem cells, researchers say
Stanford Medical Center Report
The study provides a direct and unexpected molecular link between cancer and stem cell science through retinoblastoma, or Rb, one of the best known of a class of proteins called tumor suppressors. Although Rb has long been known to control the rate of
UW-Madison researchers discover method to encourage self-renewal of stem cellsMadison.com
Stem cells can’t fix all diseases: AIIMSEconomic Times
International Stem Cell Q3 2014 Results – Earnings Call Transcript (ISCO)Seeking Alpha (registration)
Medical Xpress –MicroCap Daily
all 45 news articles »
Continue reading

2014-11-13 NEWS

Stem cell regime has no advantage over conventional treatment of stroke’
Zee News
The study that was financed by the Department of Bio-Technology stated that the general public, suffering from disabling and incurable diseases, should not go in for stem cell treatment without knowing its scientific effects as there are different

Continue reading

2014-11-13 NEWS

Bone marrow stem cell treatment has no added benefit: Study
The Hindu
Bone marrow stem cell treatment has no added benefit over the conventional treatment in paralysis, also known as stroke, reveals a study conducted by AIIMS. According to the study, people suffering from ischemic stroke should exercise caution while
International Stem Cell Corporation Announces Record Revenues and CNNMoney
Stem cell regime has no advantage over conventional treatment of stroke’Business Standard
Stem Cells Therapy Market and Emerging Biotechnologies Industry Global PR Newswire (press release)

all 12 news articles »

Continue reading

2014-11-13 NEWS

Bone marrow stem cell treatment has no added benefit: Study
The Hindu
Bone marrow stem cell treatment has no added benefit over the conventional treatment in paralysis, also known as stroke, reveals a study conducted by AIIMS. According to the study, people suffering from ischemic stroke should exercise caution while
International Stem Cell Corporation Announces Record Revenues and CNNMoney
Stem cell regime has no advantage over conventional treatment of stroke’Business Standard
Stem Cells Therapy Market and Emerging Biotechnologies Industry Global PR Newswire (press release)

all 12 news articles »

Continue reading

2014-11-13 NEWS

From Tools To Therapies: Stem Cell Maker CDI Takes One Small Step
Xconomy
There are plenty of regulatory hurdles, including a number of “safety pitfalls” that CDI “will have to avoid in their march to clinical application,” says Willy Lensch, executive director of Harvard University’s department of stem cell and regenerative
MADISON – Sales rise for stem cell company CDI but so do expensesBizTimes.com (Milwaukee)
Susan A. Willetts Joins Cellular Dynamics’ Board of DirectorsGlobeNewswire (press release)

all 8 news articles »

Continue reading

2014-11-13 NEWS

From Tools To Therapies: Stem Cell Maker CDI Takes One Small Step
Xconomy
There are plenty of regulatory hurdles, including a number of “safety pitfalls” that CDI “will have to avoid in their march to clinical application,” says Willy Lensch, executive director of Harvard University’s department of stem cell and regenerative
MADISON – Sales rise for stem cell company CDI but so do expensesBizTimes.com (Milwaukee)
Susan A. Willetts Joins Cellular Dynamics’ Board of DirectorsGlobeNewswire (press release)

all 8 news articles »